methyl 2-phenyl-2H-indazole-7-carboxylate | 952479-62-8

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 英文名称: methyl 2-phenyl-2H-indazole-7-carboxylate
• 英文别名: methyl 2-phenylindazole-7-carboxylate
• CAS: 952479-62-8
• 化学式: C₁₅H₁₂N₂O₂
• 分子量: 252.272
• InChiKey: IJQQQPMBRKBUNK-UHFFFAOYSA-N

物化性质

• 沸点：
  312.6±25.0 °C(Predicted)
• 密度：
  1.21±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.1
• 重原子数：
  19
• 可旋转键数：
  3
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.07
• 拓扑面积：
  44.1
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  methyl 2-phenyl-2H-indazole-7-carboxylate 在 氨 作用下， 以 四氢呋喃 、 水 为溶剂， 生成 2-phenyl-2H-indazole-7-carboxamide
  参考文献：
  名称：

  [EN] PHARMACEUTICALLY ACCEPTABLE SALTS OF 2-{4-[(3S)-PIPERIDIN-3- YL]PHENYL} -2H-INDAZOLE-7-CARBOXAMIDE
  [FR] SELS PHARMACEUTIQUEMENT ACCEPTABLES DE 2-{4-[(35)-PIPÉRIDIN-3-YL]PHÉNYL)-2H-INDAZOLE-7-CARBOXAMIDE

  摘要：

  本发明涉及一种酰胺取代吲唑的药用可接受盐，它们是酶聚(ADP-核糖)聚合酶（PARP）的抑制剂，此前被称为聚(ADP-核糖)合酶和聚(ADP-核糖)转移酶。本发明的化合物可用作特定DNA修复途径缺陷肿瘤的单独治疗，以及作为某些DNA损伤剂（如抗癌剂和放疗）的增效剂。此外，本发明的化合物可用于减少细胞坏死（在中风和心肌梗死中）、下调炎症和组织损伤、治疗逆转录病毒感染以及保护免受化疗毒性的影响。

  公开号：

  WO2009087381A1
• 作为产物：
  描述：

  3-甲基-2-硝基苯甲酸甲酯 在 N-溴代丁二酰亚胺(NBS) 、 sodium azide 、 N-甲基吗啉氧化物 、 过氧化苯甲酰 作用下， 以 四氯化碳 、 乙醇 、 N,N-二甲基甲酰胺 、 乙腈 为溶剂， 反应 15.5h， 生成 methyl 2-phenyl-2H-indazole-7-carboxylate
  参考文献：
  名称：

  WO2007/113596

  摘要：

  公开号：

文献信息

• [EN] PHARMACEUTICALLY ACCEPTABLE SALTS OF 2-{4-[(3S)-PIPERIDIN-3- YL]PHENYL} -2H-INDAZOLE-7-CARBOXAMIDE<br/>[FR] SELS PHARMACEUTIQUEMENT ACCEPTABLES DE 2-{4-[(35)-PIPÉRIDIN-3-YL]PHÉNYL)-2H-INDAZOLE-7-CARBOXAMIDE
  申请人：MERCK SHARP & DOHME

  公开号：WO2009087381A1

  公开（公告）日：2009-07-16

  The present invention relates to pharmaceutically acceptable salts of an amide substituted indazole which are inhibitors of the enzyme poly(ADP-ribose)polymerase (PARP), previously known as poly(ADP-ribose)synthase and poly(ADP-ribosyl)transferase. The compounds of the present invention are useful as mono-therapies in tumors with specific defects in DNA-repair pathways and as enhancers of certain DNA -damaging agents such as anticancer agents and radiotherapy. Further, the compounds of the present invention are useful for reducing cell necrosis (in stroke and myocardial infarction), down regulating inflammation and tissue injury, treating retroviral infections and protecting against the toxicity of chemotherapy.

  本发明涉及一种酰胺取代吲唑的药用可接受盐，它们是酶聚(ADP-核糖)聚合酶（PARP）的抑制剂，此前被称为聚(ADP-核糖)合酶和聚(ADP-核糖)转移酶。本发明的化合物可用作特定DNA修复途径缺陷肿瘤的单独治疗，以及作为某些DNA损伤剂（如抗癌剂和放疗）的增效剂。此外，本发明的化合物可用于减少细胞坏死（在中风和心肌梗死中）、下调炎症和组织损伤、治疗逆转录病毒感染以及保护免受化疗毒性的影响。
• Amide substituted indazoles as poly(ADP-ribose)polymerase(PARP) inhibitors
  申请人：Jones Philip

  公开号：US20080167345A1

  公开（公告）日：2008-07-10

  The present invention relates to compounds of formula I: and pharmaceutically acceptable salts, stereoisomers or tautomers thereof which are inhibitors of poly (ADP-ribose) polymerase (PARP) and thus useful for the treatment of cancer, inflammatory diseases, reperfusion injuries, ischemic conditions, stroke, renal failure, cardiovascular diseases, vascular diseases other than cardiovascular diseases, diabetes, neurodegenerative diseases, retroviral infection, retinal damage or skin senescence and UV-induced skin damage, and as chemo- and/or radiosensitizers for cancer treatment.

  本发明涉及式I的化合物及其药物可接受的盐、立体异构体或互变异构体，其为多聚（ADP核糖）聚合酶（PARP）的抑制剂，因此用于治疗癌症、炎症性疾病、再灌注损伤、缺血症、中风、肾衰竭、心血管疾病、除心血管疾病外的其他血管疾病、糖尿病、神经退行性疾病、逆转录病毒感染、视网膜损伤或皮肤衰老和紫外线诱导的皮肤损伤，并作为癌症治疗的化疗和/或放射增敏剂。
• Amide Substituted Indazole and Benzotriazole Derivatives as Poly(ADP-Ribose)Polymerase (PARP) Inhibitors
  申请人：Boueres Julia

  公开号：US20090275619A1

  公开（公告）日：2009-11-05

  The present invention relates to compounds of formula (I) and pharmaceutically acceptable salts or tautomers thereof which are inhibitors of poly (ADP-ribose) polymerase (PARP) and thus useful for the treatment of cancer, inflammatory diseases, reperfusion injuries, ischemic conditions, stroke, renal failure, cardiovascular diseases, vascular diseases other than cardiovascular diseases, diabetes, neurodegenerative diseases, retroviral infection, retinal damage or skin senescence and UV-induced skin damage, and as chemo- or radiosensitizers for cancer treatment.

  本发明涉及式(I)化合物及其药学上可接受的盐或互变异构体，它们是聚(ADP-核糖)聚合酶(PARP)的抑制剂，因此可用于治疗癌症、炎症性疾病、再灌注损伤、缺血性疾病、中风、肾衰竭、心血管疾病、除心血管疾病外的血管疾病、糖尿病、神经退行性疾病、逆转录病毒感染、视网膜损伤或皮肤衰老和紫外线诱导的皮肤损伤的治疗，以及作为化疗或放疗增敏剂用于癌症治疗。
• AMIDE SUBSTITUTED INDAZOLE AND BENZOTRIAZOLE DERIVATIVES AS POLY(ADP-RIBOSE)POLYMERASE (PARP) INHIBITORS
  申请人：Boueres Julia

  公开号：US20110201657A1

  公开（公告）日：2011-08-18

  The present invention relates to compounds of formula (I) and pharmaceutically acceptable salts or tautomers thereof which are inhibitors of poly (ADP-ribose) polymerase (PARP) and thus useful for the treatment of cancer, inflammatory diseases, reperfusion injuries, ischemic conditions, stroke, renal failure, cardiovascular diseases, vascular diseases other than cardiovascular diseases, diabetes, neurodegenerative diseases, retroviral infection, retinal damage or skin senescence and UV-induced skin damage, and as chemo- or radiosensitizers for cancer treatment.

  本发明涉及公式（I）的化合物及其药学上可接受的盐或互变异构体，这些化合物是聚（ADP核糖）聚合酶（PARP）的抑制剂，因此可用于治疗癌症、炎症性疾病、再灌注损伤、缺血性疾病、中风、肾衰竭、心血管疾病、除心血管疾病外的其他血管疾病、糖尿病、神经退行性疾病、逆转录病毒感染、视网膜损伤或皮肤衰老和紫外线诱导的皮肤损伤的治疗，以及作为癌症治疗的化疗或放疗增敏剂。
• PHARMACEUTICALLY ACCEPTABLE SALTS OF 2--2H-INDAZOLE-7-CARBOXAMIDE
  申请人：Foley Jennifer R.

  公开号：US20100286203A1

  公开（公告）日：2010-11-11

  The present invention relates to pharmaceutically acceptable salts of an amide substituted indazole which are inhibitors of the enzyme poly(ADP-ribose)polymerase (PARP), previously known as poly(ADP-ribose)synthase and poly(ADP-ribosyl) transferase. The compounds of the present invention are useful as mono-therapies in tumors with specific defects in DNA-repair pathways and as enhancers of certain DNA-damaging agents such as anticancer agents and radiotherapy. Further, the compounds of the present invention are useful for reducing cell necrosis (in stroke and myocardial infarction), down regulating inflammation and tissue injury, treating retroviral infections and protecting against the toxicity of chemotherapy.

  本发明涉及一种酰胺取代吲唑的药物可接受的盐，该药物是多聚腺苷酸核苷酸聚合酶（PARP）的抑制剂，以前称为多聚腺苷酸合成酶和多聚腺苷酸基转移酶。本发明的化合物可用作单一治疗法，用于具有特定DNA修复途径缺陷的肿瘤，并作为某些DNA损伤剂（如抗癌剂和放射治疗）的增效剂。此外，本发明的化合物还可用于减少细胞坏死（在中风和心肌梗死中），下调炎症和组织损伤，治疗逆转录病毒感染，并保护化疗的毒性。